GSK plc (GSK) stock analysis

In our weekly check, GSK plc is graded B (A to F). Of 21 checks on debt, profit, cash flow and trend: 15 pass, warnings: 6, red flags: 0.

Sector: Healthcare · Drug Manufacturers - General

Strengths

• Easily covers interest
• Profits backed by cash
• Strong free cash flow
• High return on capital

Warning signs

• High debt
• Margins falling
• Weak revenue growth
• Weak EPS growth
• Weak profit growth

Next earnings report: 2026-10-28

Similar companies

SNY · BMY · PFE · NVO · GILD · AMGN

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks graded D or F lost a third of their value 2-3 times as often as those graded A or B.

Updated 2026-10-03

Open the full analysis